Imagine you could take a medically ordered prescription and an afternoon off for a temporarily mind-altering experience. By doing this once a week for several weeks, you might dramatically increase the effectiveness of your psychotherapy. It would have no medical risk, wouldn’t cost a lot (comparatively speaking) and might even save time and money by speeding the therapeutic process. During the experience, a friend would be with you for safety and support. Later, you would discuss each experience with your therapist to ensure you fully integrated what you’d gone through.

This book contains hope for those diagnosed with treatment-resistant depression, plagued by trauma and frozen by fears. Ketamine-assisted psychotherapy has also proven effective for people with drug, alcohol, and behavioral addictions, existential depression, grief, and just feeling stuck. People with unresolved resentments, anger, and the everyday anxieties of modern life will also benefit. Ketamine-assisted psychotherapy has been enormously helpful with couples, groups, and veterans, which will be addressed in the book as well.

Entering the world of psychedelic drugs can be challenging, and many aren't sure where to start. As research continues to expand and legalization looms on the horizon for psychedelics like psilocybin, you may need a guide to navigate what psychedelics are, how they work, and their potential benefits and risks. The Psychedelic Handbook is a manual that is accessible to anyone with an interest in these substances. Packed with information on psilocybin, LSD, DMT/ayahuasca, mescaline/peyote, ketamine, MDMA, and more.

We all feel it—the distraction, the loss of focus, the addictive focus on the wrong things for too long. We bump into the zombies on their phones in the street, and sometimes they’re us. We stare in pity at the four people at the table in the restaurant, all on their phones, and then we feel the buzz in our pocket. Something has changed utterly: for most of human history, the boundary between public and private has been clear, at least in theory. Now, as Chris Hayes writes, “With the help of a few tech firms, we basically tore it down in about a decade.”

Depression affects eleven million people in the United States alone and 300 million people worldwide. It ruins lives, careers, families, and love of life. We often think of pharmaceutical treatments at the best way to treat depression, but the truth is that they don't work for everyone or they lose their efficacy for a third to half of all people with clinical depression. But help is on the way in the form of three alternative treatments coming to the forefront: electroconvulsive therapy (ECT), ketamine, and transcranial magnetic stimulation (TMS).